Everything to Know About Metocin (4-HO-MET) Pellets 21 mg

Metocin (4-HO-MET) is a synthetic psychedelic belonging to the tryptamine family. It is structurally related to psilocin, the primary psychoactive compound found in psilocybin mushrooms, but it is produced entirely in laboratories. It has no approved medical use and has been sold primarily as a research chemical. (Buy Metocin 4-HO-MET )

What Are 4-HO-MET 21 mg Pellets?

A 21 mg pellet is a pre-measured oral tablet containing 21 milligrams of 4-hydroxy-N-methyl-N-ethyltryptamine (Metocin).

Based on commonly referenced user-reported dosage ranges:

A 21 mg pellet falls within the common oral range, though individual sensitivity varies widely. What feels manageable for one person may feel significantly more intense for another. 

History

Metocin was first synthesized by chemist Alexander Shulgin during his exploration of psychedelic tryptamines in the 1970s and later described in TiHKAL. It became more widely available on the research chemical market during the late 2000s. 

Reported Effects

Users commonly describe Metocin as producing:

• Bright, colorful visual distortions

• Enhanced appreciation of music

• Altered perception of time

• Euphoria

• Emotional openness

• Increased introspection

• Visual patterning and geometry

• Enhanced colors and textures

Compared with psilocybin mushrooms, many users describe Metocin as producing particularly vivid visuals with a somewhat lighter psychological “headspace,” although this is not universal. 

Duration

Typical reported timeline after oral use:

Individual experiences can vary depending on metabolism, food intake, and other factors. 

Common Side Effects

Reported adverse effects include:

• Nausea

• Dilated pupils

• Increased heart rate

• Jaw tension

• Anxiety

• Muscle tension

• Sweating

• Difficulty sleeping after the experience

Some users also report an uncomfortable “body load,” particularly at higher doses. 

Risks

Scientific research on 4-HO-MET remains limited. Potential risks include:

• Psychological distress or panic

• Accidents due to impaired perception and judgment

• Hallucinogen Persisting Perception Disorder (HPPD), a rare but recognized risk with psychedelic use

• Unpredictable reactions depending on individual health and environment

Because long-term human safety data are lacking, the full risk profile is not well established. 

Drug Interactions

Reference sources advise particular caution with combinations involving:

• MAOIs

• SSRIs and other serotonergic medications

• Tramadol

• Stimulants

• Other psychedelics

These combinations may increase the risk of serious adverse reactions or intensify effects unpredictably. 

Product Quality Considerations

Research-chemical pellets may vary in:

• Actual dose

• Purity

• Manufacturing quality

• Identity of the substance

Without independent laboratory testing, it may not be possible to confirm that a pellet contains exactly what the label claims. Mislabeling has been documented in the broader research chemical market.

Legal Status

The legal status of 4-HO-MET varies by country. It is controlled or prohibited in some jurisdictions, while others regulate it under broader laws covering new psychoactive substances or analogues. Anyone researching or handling this compound should check the current laws in their own jurisdiction. 

Community Experiences

Online reports frequently describe Metocin as highly visual, but they also highlight considerable variability. Some users report a relatively clear-headed experience with vivid color enhancement and geometric visuals, while others experience stronger cognitive effects, nausea, or an uncomfortable body load. This variability underscores that effects cannot be predicted reliably from dose alone. 

Quick Facts

Because Metocin has not been extensively studied in humans, much of what is known comes from limited scientific literature and user reports rather than large clinical trials. That means there is substantial uncertainty regarding its long-term effects and overall safety.